| Koba Resources Limited (KOB) ORDINARY FULLY PAID |
Materials |
$12 |
New High-Grade Discovery at the Everest Prospect
|
11 Mar 2025 8:23AM |
$0.062 |
$0.042 |
fallen by
31.71%
|
|
KOB - Price-sensitive ASX Announcement
Full Release
Key Points
- Koba Resources Limited announced high-grade uranium mineralization discovery at the Everest Prospect.
- The Everest Prospect extends over 4 kilometers with multiple intercepts exceeding 1,000ppm eU3O8.
- The maiden drilling program resulted in three new high-grade discoveries: Everest, Berber, and Chivas Prospects.
- Koba is securing permits for further drilling to explore high-priority targets within the Yarramba Project.
- The Yarramba Project covers 5,000 km² and encompasses largely underexplored palaeochannels.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| King River Resources Limited (KRR) ORDINARY FULLY PAID |
Materials |
$32 |
Update - Notification of buy-back - KRR
|
11 Mar 2025 8:23AM |
$0.008 |
$0.022 |
risen by
175%
|
|
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$191 |
Update - Notification of buy-back - CAA
|
11 Mar 2025 8:23AM |
$10.300 |
$11.780 |
risen by
14.37%
|
|
| GTN Limited (GTN) ORDINARY FULLY PAID |
Communication Services |
$48 |
Update - Notification of buy-back - GTN
|
11 Mar 2025 8:23AM |
$0.580 |
$0.250 |
fallen by
56.90%
|
|
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$553 |
High-Grade Drilling Intercepts From Southern Zone At KGP
|
11 Mar 2025 8:23AM |
$0.490 |
$1.010 |
risen by
106.12%
|
|
AUC - Price-sensitive ASX Announcement
Full Release
Key Points
- Assay results returned from 33 Reverse Circulation holes for 4,116m of drilling.
- Drilling at Dingo intersected zones of exceptional high-grade gold mineralisation.
- Significant intercepts include 10m at 10.55g/t Au from 42m.
- Results from Lukin show anomalous shallow gold mineralisation.
- Near-term resource growth targeted with drilling in the Northern Zone at Datatine.
- Inaugural drilling program at Grasmere identified targeted KGP mine stratigraphy.
- Total of 12,344m drilled as part of the current 19,000m campaign.
- Results expected from the KGP Northern Zone and regional prospects along the Stanley Thrust.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carnegie Clean Energy Limited (CCE) ORDINARY FULLY PAID |
Utilities |
$24 |
ACHIEVE Milestone 1 Payment from EVE
|
11 Mar 2025 8:23AM |
$0.035 |
$0.060 |
risen by
71.43%
|
|
CCE - Price-sensitive ASX Announcement
Full Release
Key Points
- Carnegie received a milestone payment of €317,945 from EVE for the ACHIEVE+ Project.
- A further €1.8M is expected upon completing additional project milestones.
- The ACHIEVE+ Project involves deploying CETO technology in Spain.
- The project is part of Carnegie's initiative for marine renewable energy technologies.
- Funding was supported by Export Finance Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$65 |
PromarkerD outperforms conventional tests--results published
|
11 Mar 2025 8:23AM |
$0.480 |
$0.395 |
fallen by
17.71%
|
|
PIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- PromarkerD significantly outperforms conventional tests in predicting kidney decline in type 2 diabetes.
- The study was published in the peer-reviewed journal Diagnostics.
- PromarkerD was validated for predicting renal decline up to four years in advance.
- Proteomics International has launched a Reference Laboratory in California.
- PromarkerD has the potential to impact over 537 million people worldwide at risk of diabetes-related chronic kidney disease.
- The study followed 857 adults with type 2 diabetes over four years.
- PromarkerD delivered an area under the curve (AUC) of 0.88.
- PromarkerD identified 84% of individuals with normal kidney function who later developed significant kidney decline.
- The test showed a negative predictive value greater than 96% for categorizing low-risk patients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| West African Resources Limited (WAF) ORDINARY FULLY PAID |
Materials |
$4,010 |
Investor Presentation March 2025
|
11 Mar 2025 8:23AM |
$2.240 |
$3.510 |
risen by
56.70%
|
|
WAF - Price-sensitive ASX Announcement
Full Release
Key Points
- WAF targets an average production of over 420,000 ounces per year from 2024 to 2033.
- The Sanbrado gold mine has a mine life of 15 years with 1.5 million ounces in reserves.
- Kiaka Gold Project aims for 234,000 ounces per year over a 20-year lifespan.
- WAF is focused on sustainability and community investment, contributing over US$350 million in taxes and royalties.
- Active exploration on over 1300 km² of tenements with significant drilling programs planned.
- WAF plans to commence production at Kiaka in Q3 2025.
- The company aims to be a +500koz gold producer by 2030.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$105 |
Drilling confirms shallow, high-grade gold at Blackjack
|
11 Mar 2025 8:23AM |
$0.070 |
$0.096 |
risen by
37.14%
|
|
NMR - Price-sensitive ASX Announcement
Full Release
Key Points
- NMR's drilling confirms shallow, high-grade gold at Blackjack.
- Significant results include BJD201 returning 4m @ 6.27g/t Au.
- Drilling aims to twin historic holes for JORC compliance.
- NMR targets gold production from Blackjack starting Q3 CY2025.
- Drilling program completion expected in April 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID |
Health Care |
$222 |
Botanix Conference Commercial Update
|
11 Mar 2025 8:23AM |
$0.365 |
$0.113 |
fallen by
69.18%
|
|
BOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Sofdra is the first and only new chemical entity to treat primary axillary hyperhidrosis.
- The sales team will be in the field starting February 2025, followed by a full digital launch in March.
- Approximately 3.7 million patients actively seek treatment for hyperhidrosis.
- Botanix has a world-class team with extensive experience in launching dermatology products.
- The company has secured A$48 million to fund the commercial launch and platform development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paragon Care Limited (PGC) ORDINARY FULLY PAID |
Health Care |
$323 |
Transition to Non-Executive Director
|
11 Mar 2025 8:23AM |
$0.435 |
$0.195 |
fallen by
55.17%
|
|
| Singular Health Group Ltd (SHG) ORDINARY FULLY PAID |
Health Care |
$68 |
Receipt of Cornerstone Investment Funds from PNS
|
11 Mar 2025 8:22AM |
$0.235 |
$0.215 |
fallen by
8.51%
|
|
SHG - Price-sensitive ASX Announcement
Full Release
Key Points
- Singular Health received AUD$500,000 from PNS.
- Investment was previously announced on November 20, 2024.
- PNS is a Managed Service Organisation managing health plans for over 3.7 million patients.
- Funds will support Singular Health's pilot program with PNS.
- Singular Health's cash position exceeds $4.62 million post-funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Maronan Metals Limited (MMA) ORDINARY FULLY PAID |
Materials |
$121 |
Application Lodged for Mineral Development Licence
|
11 Mar 2025 8:22AM |
$0.265 |
$0.480 |
risen by
81.13%
|
|
| New Frontier Minerals Limited (NFM) ORDINARY FULLY PAID |
Materials |
$29 |
New Frontier Minerals Live Webinar
|
11 Mar 2025 8:22AM |
$0.016 |
$0.017 |
risen by
6.25%
|
|
| Love Group Global Ltd (LVE) ORDINARY FULLY PAID |
Communication Services |
$4 |
Ceasing to be a Substantial Holder
|
11 Mar 2025 8:22AM |
$0.135 |
$0.090 |
fallen by
33.33%
|
|
| Gratifii Limited (GTI) ORDINARY FULLY PAID |
Information Technology |
$37 |
Re-investment of Previous Convertible Notes
|
11 Mar 2025 8:22AM |
$0.115 |
$0.085 |
fallen by
26.09%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$315 |
Update - Notification of buy-back - SVR
|
11 Mar 2025 8:22AM |
$1.340 |
$1.670 |
risen by
24.63%
|
|
| Variscan Mines Limited (VAR) ORDINARY FULLY PAID |
Materials |
$10 |
Government Support for Novales-Udias Zinc Project
|
11 Mar 2025 8:22AM |
$0.007 |
$0.008 |
risen by
14.29%
|
|
VAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Government of Cantabria fully supports Variscan's mining plans
- Positive meeting held with Cantabria government officials
- Government committed to facilitating the Novales-Udias Zinc Project
- Formation of a coordination group proposed to expedite the project
- Local community shows strong acceptance of the mining initiative
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gratifii Limited (GTI) ORDINARY FULLY PAID |
Information Technology |
$37 |
Cleansing Notice
|
11 Mar 2025 8:22AM |
$0.115 |
$0.085 |
fallen by
26.09%
|
|
| Basin Energy Limited (BSN) ORDINARY FULLY PAID |
Energy |
$8 |
Half Yearly Report and Accounts
|
11 Mar 2025 8:22AM |
$0.017 |
$0.041 |
risen by
141.18%
|
|
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,550 |
Update - Notification of buy-back - MGH
|
11 Mar 2025 8:22AM |
$3.710 |
$4.260 |
risen by
14.82%
|
|
| Gratifii Limited (GTI) ORDINARY FULLY PAID |
Information Technology |
$37 |
Application for quotation of securities - GTI
|
11 Mar 2025 8:22AM |
$0.115 |
$0.085 |
fallen by
26.09%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$75 |
EZZ Appoints United States Manufacturing Partner
|
11 Mar 2025 8:22AM |
$1.690 |
$1.600 |
fallen by
5.33%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- EZZ Life Science has appointed GLSP Inc. as its US manufacturer.
- The partnership aims to enhance production efficiencies and improve supply chain logistics.
- Manufacturing will comply with US FDA regulations and ISO-certified quality standards.
- Products will undergo third-party laboratory testing for quality assurance.
- EZZ retains full ownership of trademarks, patents, and formulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| South32 Limited (S32) ORDINARY FULLY PAID |
Materials |
$19,830 |
Update - Notification of buy-back - S32
|
11 Mar 2025 8:22AM |
$3.610 |
$4.420 |
risen by
22.44%
|
|
| Gratifii Limited (GTI) ORDINARY FULLY PAID |
Information Technology |
$37 |
Application for quotation of securities - GTI
|
11 Mar 2025 8:21AM |
$0.115 |
$0.085 |
fallen by
26.09%
|
|